Beqvez fda approval history last updated by judith stewart, bpharm on may 21, 2024 May 21, 2024 fda approves second hemophilia b gene therapy product the u.s Yes (first approved april 26, 2024) brand name
Leaked | Scrolller
Developed by pfizer, beqvez was approved by the us food and drug administration (fda) on april 26, 2024, for adult patients with moderate to severe hemophilia b, defined as circulating factor ix activity of 2% or less.
